Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection - 04/06/15
Summary |
Objectives |
To assess associations between the functional polymorphisms G-2518A at the chemokine (C–C motif) ligand 2 gene (CCL2) and mannose binding lectin (MBL) codon 54 variant (A/B) and susceptibility to SARS.
Methods |
We genotyped the CCL2 G-2518A and MBL codon 54 variant (A/B) in 4 case–control populations of Chinese descent, totally consisting of 932 patients with SARS and 982 control subjects.
Results |
Both the high-CCL2-producing GG genotype and the low-MBL-producing B allele were consistently associated with increased risks of SARS-CoV infection in all 4 case–control populations (joint P = 1.6 × 10−4 and 4.9 × 10−8, for CCL2 and MBL respectively), with no interaction between polymorphisms could be detected. Furthermore, all the 4 case–control studies demonstrated a cumulative effect on risk of SARS-CoV infection for the combination of polymorphisms (joint P = 1.3 × 10−10). However, tests using the area under the curve (AUC) indicated that at this stage, the polymorphisms were unlikely to be appropriate for risk prediction testing because of low AUC values (all <66%). Additionally, no association was observed between the polymorphisms and severity of SARS.
Conclusions |
The CCL2 G-2518A and MBL codon 54 variant have a significantly cumulative effect on increased risk of SARS-CoV infection.
Le texte complet de cet article est disponible en PDF.Highlights |
• | This study includes the largest cohort in genetic association studies of SARS. |
• | The GG genotype at CCL2 G-2518A was associated with an increased risk of SARS-CoV infection. |
• | The MBL B allele was associated with an increased risk of SARS-CoV infection. |
• | SNPs of CCL2 and MBL cumulatively increase susceptibility to SARS-CoV infection. |
• | The joint population attributable fraction (PAF) for these two SNPs is 28.5%. |
Keywords : CCL2, MBL, Severe acute respiratory syndrome, Polymorphism, Susceptibility
Plan
Vol 71 - N° 1
P. 101-109 - juillet 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.